Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate plus simvastatin versus simvastatin monotherapy in mixed dyslipidemia
2005-003270-14Phase 3Completed
- Sponsor
- Fournier
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate and simvastatin in combined dyslipidaemia (3 arms), sponsored by Fournier. Primary endpoints: Percent change in triglycerides, Percent change in HDL cholesterol and 1 more. Started Oct 2005; status: completed.
02
Drugs
fenofibratesimvastatin
03
Conditions
combined dyslipidaemia
Beyond the preview
Go deeper on 2005-003270-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003270-14.